Blog

Geron stem cell work finds new home, reunited with Tom Okarma
San Francisco Business Times (blog)
Other cell lines include cancer, include a cancer vaccine ready for a Phase II/III trial, an orthopedics line that may target regeneration of cartilage to address osteoarthritis and human embryonic stem cell-derived cardiomyocytes that could zero in on …
Geron unloads its stem cell coffers to BioTime in stock dealFierceBiotech
Geron (GERN) Completes Embryonic Stem Cell Asset DivestitureStreetInsider.com (subscription)
Geron Completes Divestiture of Stem Cell AssetsMarketWatch
DailyFinance
all 5 news articles